| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |